The growth of this market is primarily driven by the growth of the pharmaceutical and biopharmaceutical industry, increasing demand for single-use technologies, and the advancements in nanofiltration techniques.
The global Pharmaceutical Membrane Filtration Market is valued at an estimated USD 5.1 billion in 2019 and is projected to reach USD 8.6 billion by 2024, growing at a CAGR of 11.0% during the forecast period.
Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255408031
On the basis of product, the pharmaceutical membrane filtration market is segmented into filters, systems, and accessories. Filters formed the largest product segment in this market owing to the high and growing use of different types of membrane filters for various filtration applications in the biopharmaceutical manufacturing industry.
On the basis of application, the pharmaceutical membrane filtration market is segmented into final product processing, raw material filtration, cell separation, water purification, and air purification. Final product processing was the largest application segment in the pharmaceutical membrane filtration market in 2018.
The global pharmaceutical membrane filtration market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2018, North America was the largest market for pharmaceutical membrane filtration, followed by Europe. The large share of North America can be attributed to several factors, such as the presence of key biopharmaceutical manufacturing facilities in the region and the significant spending on research and development activities in the US.
The major companies operating in the pharmaceutical membrane filtration market include Merck Millipore (Germany), Danaher (US) and Sartorius Stedim Biotech (France).